Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.
Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested today, by introducing the first “Organism-on-Chip” technology.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 21, 2022 | Grant | €2.50M | 1 |
![]() |
— | Detail |
Dec 20, 2019 | Seed | Fr1.80M | 2 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Grant |
![]() |
Yes | Seed |
|
— | Seed |